METTL14 and breast carcinoma: The RIP analysis showed the binding of METTL14 to MALAT1 in breast cancer cells (Fig. 5A) and the MeRIP-PCR assays indicated that METTL14 knockdown significantly reduced m6A modification of MALAT1 in BT474 cells (Figs. 5B and S5).